XML 36 R24.htm IDEA: XBRL DOCUMENT
v3.25.3

Assets and Liabilities Measured at Fair Value (Tables) | 9 Months Ended
--- | ---
Sep. 30, 2025
Fair Value Disclosures [Abstract] |
Schedule of Assets and Liabilities Subject to Fair Value Measurements | A summary of the fair value of the Company's recurring assets and liabilities aggregated by the level in the fair value hierarchy within which those measurements fall as of September 30, 2025 are identified in the following tables:
(in thousands) |  | Level 1 |  | Level 2 |  | Total
Assets: |  |  |  |  |  |
U.S. government agency bonds |  | $ | — |  |  | $ | 42,240 |  |  | $ | 42,240 |
Commercial paper |  | — |  |  | 18,390 |  |  | 18,390 |
Corporate debt securities |  | — |  |  | 12,507 |  |  | 12,507 |
Money market |  | 2,180 |  |  | — |  |  | 2,180 |
|  | $ | 2,180 |  |  | $ | 73,137 |  |  | $ | 75,317 |
(in thousands) |  | Level 1 |  | Level 2 |  | Total
Liabilities: |  |  |  |  |  |
Deferred compensation plan liability |  | $ | 2,080 |  |  | $ | — |  |  | $ | 2,080 |
|  | $ | 2,080 |  |  | $ | — |  |  | $ | 2,080 |
A summary of the fair value of the Company's recurring assets and liabilities aggregated by the level in the fair value hierarchy within which those measurements fall as of December 31, 2024 are identified in the following tables:
(in thousands) |  | Level 1 |  | Level 2 |  | Total
Assets: |  |  |  |  |  |
Commercial paper |  | $ | — |  |  | $ | 18,081 |  |  | $ | 18,081 |
U.S. government agency bonds |  | — |  |  | 16,518 |  |  | 16,518 |
Corporate debt securities |  | — |  |  | 1,444 |  |  | 1,444 |
Money market |  | 2,318 |  |  | — |  |  | 2,318 |
|  | $ | 2,318 |  |  | $ | 36,043 |  |  | $ | 38,361 |
(in thousands) |  | Level 1 |  | Level 2 |  | Total
Liabilities: |  |  |  |  |  |
Deferred compensation plan liability |  | 2,218 |  |  | — |  |  | 2,218 |
|  | $ | 2,218 |  |  | $ | — |  |  | $ | 2,218 |

X
- Definition Tabular disclosure of financial instrument measured at fair value on recurring or nonrecurring basis. Includes, but is not limited to, instrument classified in shareholders' equity. + References Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef -Topic 820 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 2 -Subparagraph (b) -Publisher FASB -URI https://asc.fasb.org/1943274/2147482106/820-10-50-2 Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef -Topic 820 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 2 -Subparagraph (a) -Publisher FASB -URI https://asc.fasb.org/1943274/2147482106/820-10-50-2 Reference 3: http://www.xbrl.org/2003/role/exampleRef -Topic 820 -SubTopic 10 -Name Accounting Standards Codification -Section 55 -Paragraph 100 -Publisher FASB -URI https://asc.fasb.org/1943274/2147482078/820-10-55-100 Reference 4: http://www.xbrl.org/2009/role/commonPracticeRef -Topic 820 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 3 -Subparagraph (a) -Publisher FASB -URI https://asc.fasb.org/1943274/2147482106/820-10-50-3 + Details
Name: | us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTableTextBlock
Namespace Prefix: | us-gaap_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- References No definition available. + Details
Name: | us-gaap_FairValueDisclosuresAbstract
Namespace Prefix: | us-gaap_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration